As of April 29, 2025, PepGen (PEPG) has a market cap of $52.030 million USD. According to our data, PepGen is ranked No.8082 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 29, 2025 | $52.03 M |
-57.88%
|
Dec 31, 2024 | $0.12 B |
-44.26%
|
Dec 29, 2023 | $0.22 B |
-49.14%
|
Dec 30, 2022 | $0.44 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Ionis Pharmaceuticals
IONS
|
$4.78 B |
-0.000 M
|
![]() USA
|
![]() Alnylam Pharmaceuticals
ALNY
|
$32.98 B |
-0.000 M
|
![]() USA
|
![]() Moderna
MRNA
|
$10.57 B |
-0.043 B
|
![]() USA
|
![]() BioMarin Pharmaceutical
BMRN
|
$12.08 B |
0.000 M
|
![]() USA
|
![]() CRISPR Therapeutics
CRSP
|
$3.27 B |
2.591 M
|
![]() Switzerland
|
![]() Editas Medicine
EDIT
|
$0.13 B |
-0.000 M
|
![]() USA
|
![]() Intellia Therapeutics
NTLA
|
$0.87 B |
-0.000 M
|
![]() USA
|
![]() bluebird bio
BLUE
|
$40.24 M |
0.000 M
|
![]() USA
|
![]() Sangamo Therapeutics
SGMO
|
$0.16 B |
-0.000 M
|
![]() USA
|
![]() REGENXBIO
RGNX
|
$0.47 B |
0.000 M
|
![]() USA
|
![]() Rocket Pharmaceuticals
RCKT
|
$0.78 B |
0.000 M
|
![]() USA
|
![]() Voyager Therapeutics
VYGR
|
$0.20 B |
0.000 M
|
![]() USA
|
![]() uniQure
QURE
|
$0.75 B |
0.000 M
|
![]() Netherlands
|
Market Cap | = | PEPG Stock Price | * | PEPG Shares Outstanding |
= | $1.59 | * | 32.69 M | |
= | $52.03 M |